Preclinical Project Manager to Gesynta Pharma AB

Gesynta Pharma AB continues to grow and is now looking to recruit a Preclinical Project Manager to join the company.
Gesynta Pharma is pharmaceutical company based in Stockholm developing novel oral treatments for patients with chronic inflammatory conditions. The company is led by an experienced team of pharmaceutical and medical research and development professionals and the team competency spans all essential aspects of the drug development process.

As a Preclinical Project Manager you will be responsible for coordinating pre-clinical drug development activities in Gesynta Pharma’s projects and work closely with the team members to assure effective procurement, execution and follow-up of all preclinical activities. In this stimulating role, you will have the opportunity to apply your understanding of drug development and pre-clinical technical expertise as well as taking on leadership in the ongoing projects. If this sounds interesting to you – come and join us!

The position is full-time and based in Stockholm. For the right candidate other locations in Sweden will be considered. We evaluate applications continuously and we welcome your application today!

JOB DESCRIPTION

As a Preclinical Project Manager, your main areas of responsibility will include:

• Taking operative responsibility for coordination of non-clinical project activities
• Coordinating efforts of internal stakeholders and external experts to assure effective design and procurement of pre-clinical studies
• During studies, follow up and monitor of work by experts and manage external vendors as needed
• Coordinate authoring of pre-clinical section of regulatory and other documents
• Assure financial and administrative aspects of pre-clinical activities are adequately planned and followed up in collaboration with finance and management
• Contribute subject matter expertise (subject to candidate qualifications) to projects
• As a valued team member in a small company, contribute strategically and operationally in other areas where your expertise may be beneficial

QUALIFICATIONS

The right candidate for this position fulfills the following qualifications:
• Higher education in life sciences.
• Pre-clinical drug development experience, including project management in a pharmaceutical company setting
• Knowledge in drug development with excellent understanding of its strategic and regulatory considerations
• Previous experience as a technical expert in the areas of DMPK or toxicology/safety is a strong plus
• Experience from working in a smaller pharmaceutical company is a strong plus
• Excellent written and verbal communication skills in English

We are looking for someone with an analytical mindset, attention to detail and problem-solving skills. A strong drive, dependability and ability to plan, coordinate and following up effectively are key factors to be successful in this role. Strong communication and collaboration skills are required for managing effective working relationships with both internal and external collaborators. Importantly, as we are a smaller company, we believe that you are someone who enjoys working in a dynamic environment where teamwork is key and where we support each other in order to succeed.

If you are ready to bring your skills and expertise to this position, we are ready to offer you an exciting opportunity where you will make a difference!

ABOUT GESYNTA PHARMA AB

Founded in 2017, Gesynta Pharma bases its R&D on Nobel Prize awarded research from the Karolinska Institutet. The most advanced drug candidate GS-248 reduces inflammation and increases blood flow in the microvessels, which may provide improved treatments for several serious diseases. GS-248 is being evaluated in a comprehensive Phase II program to normalize blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. The results of ongoing and planned clinical studies may allow for rapidly broadening the development towards additional indications, such as cardiovascular diseases and rheumatic diseases other than systemic sclerosis. The company's owners include Industrifonden, Hadean Ventures, Linc, and a number of successful life science entrepreneurs. For more information, visit www.gesynta.se